original ) (raw )Effect of Ruboxistaurin on Urinary Transforming Growth Factor- in Patients With Diabetic Nephropathy and Type 2 Diabetes
George Bakris
Diabetes Care, 2007
View PDFchevron_right
Effect of Ruboxistaurin on Urinary Transforming Growth Factor- β in Patients with Diabetic Nephropathy and Type 2 Diabetes
George Bakris
Diabetes Care, 2007
View PDFchevron_right
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin–angiotensin system blockade: a pilot study
Vesta Lai
Canadian Journal of Physiology and Pharmacology, 2012
View PDFchevron_right
Relationship Between Protein Kinase C and Diabetic Nephropathy Patients in Al Anbar City
Duaa Rajab
Pakistan Journal of Medical and Health Sciences
View PDFchevron_right
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy
Antonio Prato
Diabetologia, 2003
View PDFchevron_right
Deletion of Protein Kinase C-β Isoform In Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model
Joon-Keun Park
Diabetes, 2007
View PDFchevron_right
Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
Asma Alonazi
Journal of Pharmacy and Pharmacology, 2016
View PDFchevron_right
Dual Inhibition of Classical Protein Kinase C-α and Protein Kinase C-β Isoforms Protects Against Experimental Murine Diabetic Nephropathy
Joon-Keun Park
Diabetes, 2013
View PDFchevron_right
Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus
Nehal Mehta
Cardiovascular Drugs and Therapy, 2009
View PDFchevron_right
No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes: Letters
Kerry Pettigrew
Diabetic Medicine, 2008
View PDFchevron_right
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats
Daisuke Koya
Journal of Clinical Investigation, 1997
View PDFchevron_right
Protein kinase C activation and its role in kidney disease (Review Article)
Glenda Gobe
Nephrology, 2006
View PDFchevron_right
Protein kinase C in enhanced vascular tone in diabetes mellitus
Анатолий Соловьев
International Journal of Cardiology, 2014
View PDFchevron_right
Genetic Variants of the Protein Kinase C-β 1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes
Xilin Yang
JAMA, 2010
View PDFchevron_right
Effects of C-peptide on glomerular and renal size and renal function in diabetic rats
G. Jaremko
Kidney International, 2001
View PDFchevron_right
The Missing Link in Diabetic Nephropathy?
Lina Nordquist
2010
View PDFchevron_right
The β-Specific Protein Kinase C Inhibitor Ruboxistaurin (LY333531) Suppresses Glucose-Induced Adhesion of Human Monocytes to Endothelial Cells in Vitro
Thomas Kunt
Journal of Diabetes Science and Technology, 2007
View PDFchevron_right
Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-α—Deficient Diabetic Mice
Joon-Keun Park
Diabetes, 2004
View PDFchevron_right
New and old markers of progression of diabetic nephropathy
R. Macisaac
Diabetes Research and Clinical Practice, 2008
View PDFchevron_right
Role of Protein Kinase C in Diabetic Complications
Thakur Gurjeet Singh
Journal of Pharmaceutical Technology, Research and Management, 2019
View PDFchevron_right
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
Kadriye Akpınar
Brazilian Journal of Nephrology, 2021
View PDFchevron_right
Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 Diabetes
Erosha Premaratne
Diabetes Care, 2008
View PDFchevron_right
Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat
Geoffrey Boner
Journal of the renin-angiotensin-aldosterone system : JRAAS, 2004
View PDFchevron_right
Protein kinase C inhibition in diabetic retinopathy and microvascular disease
Aniz Girach
Practical Diabetes International, 2007
View PDFchevron_right
Long-term effects of vitamin C supplementation on glomerular changes in streptozotocin-induced diabetic rats
Narongsak Chaiyabutr
Asian Biomedicine, 2007
View PDFchevron_right
Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes
Catherine Lasseur
Diabetes & Metabolism, 2008
View PDFchevron_right
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
Janet McGill
Clinical Journal of the American Society of Nephrology, 2007
View PDFchevron_right
Protein Kinase C- Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus
Melissa Farb
Circulation, 2013
View PDFchevron_right
Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy
Alan Shenkin
Cytokine, 2009
View PDFchevron_right
Pharmacologic inhibition of Protein Kinase C α and Protein Kinase C β halts renal function decline indirectly, by blunting hyperphagia, and directly reduces adiposity in the ZSF1 rat model of type 2 diabetes
Hank Lin
2020
View PDFchevron_right
Protein Kinase C–Dependent Increase in Reactive Oxygen Species (ROS) Production in Vascular Tissues of Diabetes: Role of Vascular NAD(P)H Oxidase
Toyoshi Inoguchi
Journal of the American Society of Nephrology, 2003
View PDFchevron_right
Renal endothelial protein C receptor expression and shedding in diabetic nephropathy
Jaklien Leemans
Journal of Thrombosis and Haemostasis, 2016
View PDFchevron_right